Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Sale
Common Stock
2021-01-08$11.68/sh−1,690$19,739→ 35,810 total
Footnotes (1)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on January 31, 2020 for 7,500 shares.